Title:
INJECTION FORMULATION
Document Type and Number:
WIPO Patent Application WO/2021/039084
Kind Code:
A1
Abstract:
[Problem] To provide a sugammadex sodium injection formulation capable of suppressing fluctuations in foreign substances such as analog substances and being stably preserved for a long period of time. [Solution] An injection formulation comprising: a medical container having an oxygen-permeable container, in which a sugammadex sodium aqueous solution containing sugammadex sodium as an active ingredient is filled and under undergoes high pressure steam sterilization; and an oxygen permeation-retardant packaging container, wherein (i) the medical container is accommodated and hermetically sealed, together with an oxygen scavenger, inside the oxygen permeation-retardant packaging container, or (ii) the medical container is accommodated and hermetically sealed inside the oxygen permeation-retardant packaging container, into which an inert gas has been substituted.
More Like This:
Inventors:
YOSHIKAWA HIROKI (JP)
ITO HIROSHI (JP)
YAMAMOTO SATOSHI (JP)
ITO HIROSHI (JP)
YAMAMOTO SATOSHI (JP)
Application Number:
PCT/JP2020/025042
Publication Date:
March 04, 2021
Filing Date:
June 25, 2020
Export Citation:
Assignee:
TERUMO CORP (JP)
International Classes:
A61P21/00; A61J1/00; A61J1/05; A61K9/08; A61K31/724
Domestic Patent References:
| WO2016051962A1 | 2016-04-07 | |||
| WO2015147305A1 | 2015-10-01 | |||
| WO2001040316A1 | 2001-06-07 |
Foreign References:
| JP2016512455A | 2016-04-28 | |||
| JP3880041B2 | 2007-02-14 | |||
| JP2018076533A | 2018-05-17 | |||
| JP2006016053A | 2006-01-19 | |||
| JP3880041B2 | 2007-02-14 | |||
| JP2019158309A | 2019-09-19 |
Other References:
"Report on the examination result of BRIDION intravenous 200 mg and same intravenous 500 mg", 27 October 2009, EVALUATION AND LICENSING DIVISION
"Japanese Pharmacopoeia"
"Japanese Pharmacopoeia"
Attorney, Agent or Firm:
HATTA & ASSOCIATES (JP)
Download PDF: